for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Burcon NutraScience Corp

BU.TO

Latest Trade

1.30CAD

Change

0.04(+3.17%)

Volume

180,149

Today's Range

1.25

 - 

1.33

52 Week Range

0.13

 - 

1.98

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1.26
Open
1.27
Volume
180,149
3M AVG Volume
18.98
Today's High
1.33
Today's Low
1.25
52 Week High
1.98
52 Week Low
0.13
Shares Out (MIL)
88.20
Market Cap (MIL)
111.13
Forward P/E
-21.00
Dividend (Yield %)
--

Next Event

Q2 2020 Burcon NutraScience Corp Earnings Release

Latest Developments

More

Burcon Announces Execution Of Loan Agreement

Burcon Nutrascience Reports Qtrly Basic And Diluted Loss Per Share C$0.04

Burcon announces fiscal 2017 results and reviews operations

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Burcon NutraScience Corp

Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates. The Company's products are targeted at the protein ingredient market and are particularly suited to health and wellness applications. The CLARISOY portfolio includes CLARISOY 100, 110, 120 and 150 for low potential of Hydrogen (pH) applications, and CLARISOY 170 and 180 for neutral applications. Peazazz is well-suited for use in low pH and neutral pH beverages, dairy alternative products, meal replacements, as well as a range of other healthy food and beverage product applications.

Industry

Biotechnology & Drugs

Contact Info

1946 Broadway W

+1.604.7330896

https://www.burcon.ca/

Executive Leadership

David Lorne John Tyrrell

Chairman of the Board

Johann F. Tergesen

President, Chief Executive Officer, Chief Operating Officer

Jade Cheng

Chief Financial Officer, Treasurer

Dorothy K. T. Law

Senior Vice President - Legal, Corporate Secretary

Randy Willardsen

Senior Vice President - Process

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, CAD)

2020(E)

0.0K
EPS (CAD)

2020(E)

-0.060
Price To Earnings (TTM)
--
Price To Sales (TTM)
2,266.06
Price To Book (MRQ)
9.14
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-74.61
Return on Equity (TTM)
-59.09

Latest News

Latest News

BRIEF-Burcon Announces Delisting From Nasdaq Capital Market

* BURCON ANNOUNCES DELISTING FROM NASDAQ CAPITAL MARKET Source text for Eikon: Further company coverage:

BRIEF-Burcon Nutrascience Reports Qtrly Basic And Diluted Loss Per Share C$0.04

* BURCON NUTRASCIENCE CORP - QTRLY BASIC AND DILUTED LOSS PER SHARE C$0.04 Source text: (http://bit.ly/2EslCS7) Further company coverage:

BRIEF-Burcon Files Application For Controlled Drugs And Substances License

* BURCON FILES APPLICATION FOR CONTROLLED DRUGS AND SUBSTANCES LICENSE TO PURSUE THE PURIFIED CANNABINOIDS MARKET Source text for Eikon: Further company coverage:

BRIEF-Burcon announces fiscal 2017 results and reviews operations

* Burcon announces fiscal 2017 results and reviews operations

BRIEF-Burcon announces rights offering

* Says the rights will be listed for trading on TSX beginning on November 1, 2016 under symbol "BU.RT"

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up